Transdermal Hyoscine (Scopolamine) A Preliminary Review of its Pharmacodynamic Properties and Therapeutic Efficacy

Permeability of the skin

1971 • 1,388 citations

Drug permeation through human skin: Theory and invitro experimental measurement

1975 • 770 citations

Motion sickness.

1970 • 358 citations

The central effects of scopolamine in man.

1971 • 190 citations

Transdermal scopolamine in the prevention of motion sickness at sea

1981 • 105 citations

Pharmacokinetics of Drug Permeation through Human Skin

1978 • 105 citations

Drugs used in motion sickness. A critical review of the methods available for the study of drugs of potential value in its treatment and of the information which has been derived by these methods.

1966 • 73 citations

Programmed, systemic drug delivery by the transdermal route

1979 • 71 citations

Controlled Topical Delivery of Drugs for Systemic Action

1978 • 68 citations

Scopolamine permation through human skin in vitro

1976 • 61 citations

Prevention of experimental motion sickness by scopolamine absorbed through the skin.

1976 • 51 citations

Rate-controlled Drug Dosage

1982 • 45 citations

Submicrogram Assay for Scopolamine in Plasma and Urine

1975 • 45 citations

Transdermal scopolamine in the prevention of motion sickness: evaluation of the time course of efficacy.

1983 • 44 citations

Theory of antimotion sickness drug mechanisms.

1972 • 42 citations

Transdermal Scopolamine in the Treatment of Acute Vertigo

1984 • 39 citations

Effect of transdermally administered scopolamine in preventing motion sickness

1981 • 38 citations

Transdermal scopolamine psychosis.

1982 • 38 citations

Anisocoria from scopolamine patches.

1982 • 30 citations

(—)‐HYOSCINE AND CYCLIZINE AS MOTION SICKNESS REMEDIES

1967 • 30 citations

A comparison of plasma levels of hyoscine after oral and transdermal administration

1983 • 29 citations

Transdermal scopolamine, oral meclizine, and placebo in motion sickness

1984 • 28 citations

Antimotion-sickness efficacy of scopolamine 12 and 72 hours after transdermal administration.

1982 • 26 citations

Results of a randomized double-blind crossover trial of scopolamine versus placebo administered by transdermal patch for the control of cisplatin-induced emesis.

1982 • 26 citations

Effective Antiemetic Agents

1957 • 25 citations

A Reduction of Vestibulo-visual Integration during Transdermally Administered Scopolamine and Dimenhydrinate: A Presentation of Gain Control Theory in Motion Sickness

1983 • 24 citations

Transdermal Scopolamine in Motion Sickness

1982 • 22 citations

Controlled Release of Scopolamine for Prophylaxis of Motion Sickness

1983 • 21 citations

Prevention and treatment of space sickness in shuttle-orbiter missions.

1979 • 21 citations

Experimental motion sickness: efficacy of transdermal scopolamine plus ephedrine.

1981 • 19 citations

A comparison of effectiveness of some antimotion sickness drugs using recommended and larger than recommended doses as tested in the slow rotation room. NSAM-945.

1965 • 18 citations

REVIEW OF ANTIMOTION SICKNESS DRUGS FROM 1954-1964.

1965 • 17 citations

SCOPOLAMINE DOES NOT PREVENT POST-OPERATIVE EMESIS AFTER PEDIATRIC EYE SURGERY

1984 • 16 citations

INTRAMUSCULAR HYOSCINE IN CONTROL OF MOTION SICKNESS

1970 • 12 citations

TRANSDERMAL SCOPOLAMINE AS A PREANESTHETIC DRUG AND POSTOPERATIVE ANTINAUSEANT AND ANTIMETIC

1982 • 12 citations

Effect of transdermally administered hyoscine methobromide on nocturnal acid secretion in patients with duodenal ulcer.

1982 • 10 citations

Scopoderm-TTS� (Scopolamine) Influence on Caloric-Induced Nystagmus: an Extract

2015 • 9 citations

Motion sickness.

1955 • 9 citations

A case report: unilateral cycloplegia resulting from careless use of Transderm-V.

1982 • 6 citations

Side effects of some antimotion sickness drugs as measured by psychomotor test and questionnaires.

1966 • 6 citations